In rodents, TNF- and interleukin-1 (IL-1) both act directly on pituitary prolactinocytes to stimulate prolactin release, a process that differs from the indirect mechanism regulated by hypothalamic dopamine ( 6 A bidirectional neuroendocrinemetabolic network Hyperprolactinemia is closely related to obesity at both epidemiological and pathogenic levels
Wegovy Wegovy is a higher-dose version of semaglutide specifically approved for weight loss
Mostly it does this by removing lactate and transforming pyruvate (a by-product of glucose breakdown) from the enzyme pyruvate dehydrogenase into the energy molecule acetyl-coA, which can then be oxidized for energy production
Spain: Private Market Leading the Way In Spain: Wegovy and Saxenda are approved for weight management Public healthcare usually only covers these medicines for treating type 2 diabetes Some regions are testing small public access programmes, but they are not common yet Private costs in Spain: About 250 to 350 per month for Wegovy About 200 to 300 per month for Saxenda Who prescribes GLP-1s in Spain
This may include before-and-after photos, patient testimonials, and the spas overall reputation in the community